Search

Cell therapies for hearing loss

Cell therapies could offer a way to repair damage to the auditory system and reverse many types of hearing loss. This article looks at the progress being made.

What you need to know about recent advances in genetics of hearing loss in the newborn

Identifying the underlying genetic cause of hearing loss in newborns can improve dramatically the early diagnosis and appropriate intervention. Hearing loss is the most common sensory disorder at birth, affecting approximately two out of 1000 newborns [1]. Congenital impaired hearing...

Implicit bias in audiology and wider healthcare

What is implicit bias and how might it affect patient outcomes in hearing healthcare? Yovina Khiroya provides insight into the terminology and the effect on people and service delivery. As much as possible within healthcare, we try to reduce implicit...

Tinnitus treatment device from concept to commercialisation

Innovation in the field of healthcare is fraught with nearly insurmountable challenges. Bringing a novel product to the market requires a new (patentable) idea that can be reduced to practice, manufactured at scale, and can pass all regulatory barriers. In...

AI reshaping the landscape of head and neck cancer

With artificial intelligence set to transform almost every aspect of life, Abishek Mahajan reviews its potential to improve head and neck cancer care. Artificial intelligence (AI) has emerged as a transformative tool in healthcare. In the realm of oncology, AI...

BACO International 2018: Key Speakers

Prof Aldo C Stamm, MD, MSc, PhD Anatomy of the paranasal sinuses and skull base, and breaking the paradigms in severe spontaneous epistaxis It is a true honour to participate as an invited faculty member at the upcoming BACO International...

Jameel Muzaffar, Anne Schilder and James O’Hara

In a follow-up to the interview with Anne Schilder back in 2016*, Jameel Muzaffar speaks to Anne and to James O’Hara about the current research landscape in ENT in the UK. *Banerjee A. In conversation with Professor Anne Schilder. ENT...

Genomic testing for deafness and its implications

Gene therapies for hearing loss are rapidly advancing and will be transitioning to clinical practice. Here, the authors explain why clinicians involved in managing these disorders need to be aware of these advances. Genomic testing in England was significantly reconfigured...

The role of objective measures and imaging to optimise cochlear implant outcomes

Should we be using new or novel objective measures and imaging to assist with our cochlear implant patients? Debi Vickers and Shak Saeed describe current clinical techniques and present advances that have the potential to optimise outcomes. Introduction It is...

Acoustic shock: definitions and clinical aspects

Acoustic shock, a previously little-known and poorly understood clinical entity, came to the public’s attention in 2019 due to a high-profile legal case of a musician at the Royal Opera House. In this fascinating article, Andrew Parker and William Parker...